Investing in the communities it serves isn’t new to Dartmouth-Hitchcock Health, but the impact of such investments was never more apparent than in the past year.
Dartmouth-Hitchcock’s research on COVID-19 treatments has directly benefited patients like Robert Trembley.
These times are most often described as difficult, extraordinary, challenging, and unprecedented. But let’s be honest. The nine […]
With forecasts indicating that COVID-19 could claim 40 million lives and reduce global economic output by $12 trillion by the end of 2021, there is not a moment to lose.
When COVID-19 threatened to deplete supplies of PPE, the community responded.
An academic-industry collaboration has put a new, low-cost COVID-19 test on the fast track.
Within a month of its launch, the D-HH COVID-19 Community Relief Fund was benefiting people in need.
No one chooses when to get cancer—which makes this year’s Virtual Prouty more important than ever.
Dartmouth-Hitchcock Medical Center was one of the first 20 sites worldwide participating in clinical trials of remdesivir.